BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

IART

Integra Lifesciences Holdings Corp.
Nasdaq · Surgical & medical instruments & apparatus (SIC 3841) · FY ends 31 Dec

Revenue, quarterly

$411M+2.3% year on year
$600M$400M$200M$0
Q4 ’21Q1 ’23Q2 ’24Q2 ’25Q3 ’26
Company filings · 10-Q filed 23 Oct 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

52.4%+0.0 pp year on year
65%60%55%50%
Q4 ’21Q1 ’23Q2 ’24Q2 ’25Q3 ’26
Company filings · 10-Q filed 23 Oct 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$252M+8.6% year on year
$600M$400M$200M$0
Q4 ’21Q1 ’23Q2 ’24Q2 ’25Q3 ’26
Company filings · 10-Q filed 23 Oct 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

$86M
$400M$200M$0−$200M
Q4 ’21Q1 ’23Q2 ’24Q2 ’25Q3 ’26
Company filings · 10-Q filed 23 Oct 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty